RxDoctor Payments Data

Jon Jackson

Psychiatry · Jackson, MSNPI 1760669345

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $706,297 of the $833,744 with a category attached, or 84.7%. Alkermes, Inc. accounts for 76.3% of it on its own, with 18 other manufacturers making up the rest. Among psychiatry clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$833,744in general payments, 2019–2025

Across 1,181 payments — averaging $705.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$636K
  • Teva Pharmaceuticals USA, Inc.$194K
  • Neurocrine Biosciences, Inc.$693
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$602
  • Johnson & Johnson$389
  • Lundbeck LLC$327
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$14,8102%
  • Speaking & faculty fees$706,29785%
  • Travel & lodging$89,35111%
  • Food & beverage$23,2863%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$833,744 in reported general payments places this provider in the 95th percentile of 219 psychiatry providers in Mississippi.

See all psychiatry providers in Mississippi

Other psychiatry in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →